John Goss Selected Research

Genomic Instability

4/2009

DNA damage response pathways in tumor suppression and cancer treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John Goss Research Topics

Disease

4	Infections 08/2023 - 01/2017
4	Fibrosis (Cirrhosis) 06/2021 - 05/2003
3	Hepatocellular Carcinoma (Hepatoma) 10/2023 - 06/2021
3	End Stage Liver Disease 01/2023 - 12/2021
3	Liver Diseases (Liver Disease) 12/2021 - 10/2011
3	Liver Failure 01/2021 - 04/2017
3	Neoplasms (Cancer) 01/2021 - 01/2002
3	Hyperammonemia 12/2019 - 10/2004
3	Biliary Atresia 01/2019 - 10/2011
2	Pathologic Constriction (Stenosis) 08/2023 - 10/2004
2	Thrombocytopenia (Thrombopenia) 08/2023 - 05/2003
2	Critical Illness (Critically Ill) 02/2022 - 04/2017
2	Acute Liver Failure (Fulminant Hepatic Failure) 01/2021 - 01/2018
2	Cardiomyopathies (Cardiomyopathy) 01/2019 - 10/2011
2	Hepatoblastoma 01/2018 - 06/2016
2	Dementia (Dementias) 01/2018 - 03/2015
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2024
1	Exanthema (Rash) 01/2024
1	Absent radii and thrombocytopenia 08/2023
1	Proctocolitis (Hemorrhagic Proctocolitis) 08/2023
1	Inborn Genetic Diseases (Disease, Hereditary) 08/2023
1	Leukemoid Reaction 08/2023
1	Emphysema 06/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 06/2023
1	Craniocerebral Trauma (Head Injury) 06/2023
1	Liver Neoplasms (Liver Cancer) 01/2023
1	Portal Hypertension 01/2023
1	Cholangitis 01/2023
1	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2022
1	COVID-19 12/2021
1	Hypernatremia 10/2021
1	Hepatitis 06/2021
1	Non-alcoholic Fatty Liver Disease 06/2021
1	Hepatitis C 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Methylmalonic acidemia 12/2019
1	Hyperlactatemia 12/2019
1	Acidosis 12/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2019
1	Mucormycosis 01/2019
1	Ethylmalonic encephalopathy 01/2019
1	Pruritus (Itching) 05/2018
1	Alagille Syndrome (Alagille-Watson Syndrome) 05/2018
1	Multiple Organ Failure (MODS) 01/2018
1	Hepatorenal Syndrome 01/2018
1	Hepatic Encephalopathy 01/2018
1	Acute-On-Chronic Liver Failure 01/2018
1	Body Weight (Weight, Body) 04/2017
1	Disease Susceptibility (Diathesis) 08/2011
1	Genomic Instability 04/2009
1	Ataxia Telangiectasia (Louis Bar Syndrome) 04/2009
1	Ornithine Carbamoyltransferase Deficiency Disease 10/2004

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 08/2023 - 01/2018
2	SodiumIBA 12/2021 - 04/2017
2	CreatinineIBA 10/2021 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 04/2009
1	AntibodiesIBA 08/2023
1	Blood Group Antigens (Blood Groups)IBA 06/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 06/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	BilirubinIBA 01/2023
1	TRPP Cation ChannelsIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 10/2021
1	LipidsIBA 06/2021
1	CholesterolIBA 06/2021
1	sulfur dioxygenaseIBA 01/2019
1	AlbuminsIBA 01/2018
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2017
1	Phosphotransferases (Kinase)IBA 04/2009
1	Urea (Carbamide)FDA LinkGeneric 10/2004
1	Carbamyl Phosphate (Carbamoyl Phosphate)IBA 10/2004
1	oprelvekin (Neumega)FDA Link 05/2003
1	Interleukin-11 (Interleukin 11)IBA 05/2003

Therapy/Procedure

17	Liver Transplantation 01/2024 - 10/2004
8	Transplantation 01/2023 - 10/2004
4	Therapeutics 01/2018 - 10/2004
2	Length of Stay 01/2018 - 03/2015
2	Critical Care (Surgical Intensive Care) 01/2018 - 04/2017
1	Tracheostomy 02/2022
1	Hepatic Portoenterostomy 05/2018
1	Plasma Exchange 01/2018
1	Hybrid Renal Replacement Therapy 01/2018
1	Continuous Renal Replacement Therapy 01/2018
1	Artificial Respiration (Mechanical Ventilation) 04/2017
1	Renal Dialysis (Hemodialysis) 04/2017
1	Immunotherapy 01/2002